MedPath

Ammonia

These highlights do not include all the information needed to use Ammonia N 13 Injection safely and effectively. See full prescribing information for Ammonia N 13 Injection. Ammonia N 13 Injection for intravenous use Initial U.S. Approval: 2007

Approved
Approval ID

26572b37-0999-4c83-8206-1c088026d407

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Kreitchman PET Center

DUNS: 010861487

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AMMONIA N-13

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62072-456
Application NumberANDA203938
Product Classification
M
Marketing Category
C73584
G
Generic Name
AMMONIA N-13
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 17, 2020
FDA Product Classification

INGREDIENTS (1)

AMMONIA N-13Active
Quantity: 37.5 mCi in 1 mL
Code: 9OQO0E343Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ammonia - FDA Drug Approval Details